» Articles » PMID: 20086256

Barriers to Insulin Initiation: the Translating Research into Action for Diabetes Insulin Starts Project

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2010 Jan 21
PMID 20086256
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Reasons for failing to initiate prescribed insulin (primary nonadherence) are poorly understood. We investigated barriers to insulin initiation following a new prescription.

Research Design And Methods: We surveyed insulin-naïve patients with poorly controlled type 2 diabetes, already treated with two or more oral agents who were recently prescribed insulin. We compared responses for respondents prescribed, but never initiating, insulin (n = 69) with those dispensed insulin (n = 100).

Results: Subjects failing to initiate prescribed insulin commonly reported misconceptions regarding insulin risk (35% believed that insulin causes blindness, renal failure, amputations, heart attacks, strokes, or early death), plans to instead work harder on behavioral goals, sense of personal failure, low self-efficacy, injection phobia, hypoglycemia concerns, negative impact on social life and job, inadequate health literacy, health care provider inadequately explaining risks/benefits, and limited insulin self-management training.

Conclusions: Primary adherence for insulin may be improved through better provider communication regarding risks, shared decision making, and insulin self-management training.

Citing Articles

Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3.

Li Y, Kar S, Li C, Liu M, Luan Z, Yuan G Diabetes Ther. 2025; .

PMID: 40016570 DOI: 10.1007/s13300-025-01701-2.


Pharmacoequity measurement framework: A tool to reduce health disparities.

Patel P, Essien U, Happe L J Manag Care Spec Pharm. 2025; 31(2):214-224.

PMID: 39912813 PMC: 11801364. DOI: 10.18553/jmcp.2025.31.2.214.


Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis.

Loktionova M, Mohammadian M, Choopani R, Kheiri S, Mohammadian-Hafshejani A PLoS One. 2024; 19(12):e0314565.

PMID: 39636922 PMC: 11620406. DOI: 10.1371/journal.pone.0314565.


Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes.

Dualib P, Dib S, Augusto G, Truzzi A, de Paula M, Rea R Diabetol Metab Syndr. 2024; 16(1):152.

PMID: 38982528 PMC: 11232174. DOI: 10.1186/s13098-024-01385-x.


The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review.

McGill J, Hirsch I, Parkin C, Aleppo G, Levy C, Gavin 3rd J Diabetes Ther. 2024; 15(5):1085-1098.

PMID: 38573469 PMC: 11043311. DOI: 10.1007/s13300-024-01569-8.


References
1.
Karter A, Parker M, Moffet H, Ahmed A, Schmittdiel J, Selby J . New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009; 44(5 Pt 1):1640-61. PMC: 2754552. DOI: 10.1111/j.1475-6773.2009.00989.x. View

2.
Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

3.
Huang E, Brown S, Thakur N, Carlisle L, Foley E, Ewigman B . Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2008; 32(2):311-6. PMC: 2628700. DOI: 10.2337/dc08-1307. View

4.
Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C . Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003; 163(1):83-90. DOI: 10.1001/archinte.163.1.83. View

5.
. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care. 2002; 25(2):386-9. DOI: 10.2337/diacare.25.2.386. View